VOLORIDGE INVESTMENT MANAGEMENT, LLC - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 214 filers reported holding SAGE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.

Quarter-by-quarter ownership
VOLORIDGE INVESTMENT MANAGEMENT, LLC ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,460,521
-65.8%
70,968
-46.3%
0.01%
-68.2%
Q2 2022$4,267,000
+190.1%
132,101
+197.3%
0.02%
+175.0%
Q1 2022$1,471,000
-74.2%
44,440
-66.9%
0.01%
-74.2%
Q4 2021$5,711,000
-46.3%
134,245
-44.1%
0.03%
-55.1%
Q3 2021$10,644,000
+27.9%
240,207
+63.9%
0.07%
+19.0%
Q2 2021$8,325,000
-33.4%
146,546
-12.3%
0.06%
-36.3%
Q1 2021$12,504,000
-17.3%
167,059
-4.4%
0.09%
-28.3%
Q4 2020$15,113,000
+49.6%
174,699
+5.7%
0.13%
+51.2%
Q3 2020$10,100,000
-30.1%
165,247
-52.4%
0.08%
-49.1%
Q2 2020$14,443,000
+146.8%
347,353
+70.5%
0.16%
-1.8%
Q1 2020$5,851,000
+389.6%
203,712
+1130.8%
0.17%
+630.4%
Q4 2019$1,195,000
-51.4%
16,551
-5.6%
0.02%
-46.5%
Q3 2019$2,458,000
-72.3%
17,524
-67.5%
0.04%
-77.8%
Q4 2017$8,879,000
+50.7%
53,908
-27.1%
0.19%
+32.0%
Q2 2017$5,890,000
-0.6%
73,953
-11.3%
0.15%
+2.1%
Q1 2017$5,924,000
+130.8%
83,353
+65.8%
0.14%
+161.8%
Q4 2016$2,567,00050,2660.06%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Finepoint Capital LP 475,600$15,362,0005.31%
Integral Health Asset Management, LLC 412,257$13,316,0002.74%
Palo Alto Investors LP 851,409$27,501,0002.40%
Boxer Capital, LLC 1,094,000$35,336,0002.24%
DAFNA Capital Management LLC 180,306$5,824,0001.59%
Ikarian Capital, LLC 250,000$8,075,0001.47%
Bellevue Group AG 2,973,178$96,034,0001.36%
SECTOR GAMMA AS 118,476$3,827,0000.86%
Artal Group S.A. 450,000$14,535,0000.78%
Diametric Capital, LP 19,393$626,0000.46%
View complete list of SAGE THERAPEUTICS INC shareholders